Stifel cuts BridgeBio Oncology price target to $15 from $23
Benzinga/TradingView reports Stifel cut its BridgeBio Oncology price target to $15.00 per share from $23.00.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.